Cargando...

CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression

Background: Currently, it is difficult to predict the prognosis of patients exhibiting stage II or stage III colorectal cancer (CRC) and to identify those patients most likely to benefit from aggressive treatment. The current study was performed to examine the clinicopathological significance of CD4...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Clin Exp Pathol
Autores principales: Zhao, LH, Lin, QL, Wei, J, Huai, YL, Wang, KJ, Yan, HY
Formato: Artigo
Lenguaje:Inglês
Publicado: e-Century Publishing Corporation 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4348888/
https://ncbi.nlm.nih.gov/pubmed/25755763
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!